Patients with Relapsed/Refractory AML may Benefit from Treatment with Ficlatuzumab + …,

The investigational drug is currently being evaluated in a number of clinical trials for the treatment of both solid and hematological malignancies, …, The investigational drug is currently being evaluated in a number of clinical trials for the treatment of both solid and hematological malignancies, …, Read More

Scroll to Top